Annual Accounts Payable
$132.61 M
-$83.91 M-38.75%
December 31, 2023
Summary
- As of February 7, 2025, NVAX annual accounts payable is $132.61 million, with the most recent change of -$83.91 million (-38.75%) on December 31, 2023.
- During the last 3 years, NVAX annual accounts payable has risen by +$78.28 million (+144.07%).
- NVAX annual accounts payable is now -38.75% below its all-time high of $216.52 million, reached on December 31, 2022.
Performance
NVAX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$57.52 M
-$22.45 M-28.07%
September 30, 2024
Summary
- As of February 7, 2025, NVAX quarterly accounts payable is $57.52 million, with the most recent change of -$22.45 million (-28.07%) on September 30, 2024.
- Over the past year, NVAX quarterly accounts payable has dropped by -$44.40 million (-43.56%).
- NVAX quarterly accounts payable is now -85.12% below its all-time high of $386.49 million, reached on June 30, 2022.
Performance
NVAX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NVAX Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -38.8% | -43.6% |
3 y3 years | +144.1% | -54.7% |
5 y5 years | +1325.8% | +2184.2% |
NVAX Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -38.8% | +4.4% | -85.1% | at low |
5 y | 5-year | -38.8% | +4457.0% | -85.1% | +2184.2% |
alltime | all time | -38.8% | >+9999.0% | -85.1% | >+9999.0% |
Novavax Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $57.52 M(-28.1%) |
Jun 2024 | - | $79.96 M(+38.5%) |
Mar 2024 | - | $57.72 M(-56.5%) |
Dec 2023 | $132.61 M(-38.8%) | $132.61 M(+30.1%) |
Sep 2023 | - | $101.91 M(+16.8%) |
Jun 2023 | - | $87.25 M(-30.1%) |
Mar 2023 | - | $124.80 M(-42.4%) |
Dec 2022 | $216.52 M(+70.4%) | $216.52 M(+49.3%) |
Sep 2022 | - | $145.00 M(-62.5%) |
Jun 2022 | - | $386.49 M(+186.0%) |
Mar 2022 | - | $135.13 M(+6.4%) |
Dec 2021 | $127.05 M(+133.8%) | $127.05 M(+113.3%) |
Sep 2021 | - | $59.56 M(-19.5%) |
Jun 2021 | - | $74.00 M(-34.9%) |
Mar 2021 | - | $113.61 M(+109.1%) |
Dec 2020 | $54.33 M(+1767.1%) | $54.33 M(+259.9%) |
Sep 2020 | - | $15.10 M(+63.4%) |
Jun 2020 | - | $9.24 M(+267.0%) |
Mar 2020 | - | $2.52 M(-13.5%) |
Dec 2019 | $2.91 M(-68.7%) | $2.91 M(-30.9%) |
Sep 2019 | - | $4.21 M(-2.2%) |
Jun 2019 | - | $4.30 M(-30.0%) |
Mar 2019 | - | $6.15 M(-33.9%) |
Dec 2018 | $9.30 M(+65.7%) | $9.30 M(+37.0%) |
Sep 2018 | - | $6.79 M(+1.6%) |
Jun 2018 | - | $6.69 M(+15.9%) |
Mar 2018 | - | $5.77 M(+2.8%) |
Dec 2017 | $5.61 M(-1.3%) | $5.61 M(+7.1%) |
Sep 2017 | - | $5.24 M(-34.6%) |
Jun 2017 | - | $8.02 M(+111.6%) |
Mar 2017 | - | $3.79 M(-33.3%) |
Dec 2016 | $5.68 M(-52.2%) | $5.68 M(-65.0%) |
Sep 2016 | - | $16.23 M(+1.5%) |
Jun 2016 | - | $15.99 M(+42.3%) |
Mar 2016 | - | $11.24 M(-5.5%) |
Dec 2015 | $11.89 M(-7.9%) | $11.89 M(+45.0%) |
Sep 2015 | - | $8.20 M(+15.2%) |
Jun 2015 | - | $7.12 M(-26.9%) |
Mar 2015 | - | $9.74 M(-24.5%) |
Dec 2014 | $12.91 M(+115.7%) | $12.91 M(+333.9%) |
Sep 2014 | - | $2.98 M(-33.8%) |
Jun 2014 | - | $4.50 M(+11.9%) |
Mar 2014 | - | $4.02 M(-32.9%) |
Dec 2013 | $5.99 M(+85.4%) | $5.99 M(+79.2%) |
Sep 2013 | - | $3.34 M(+13.3%) |
Jun 2013 | - | $2.95 M(+35.6%) |
Mar 2013 | - | $2.17 M(-32.7%) |
Dec 2012 | $3.23 M(+22.0%) | $3.23 M(+46.5%) |
Sep 2012 | - | $2.20 M(-34.8%) |
Jun 2012 | - | $3.38 M(+14.2%) |
Mar 2012 | - | $2.96 M(+11.9%) |
Dec 2011 | $2.65 M(-26.0%) | $2.65 M(+10.4%) |
Sep 2011 | - | $2.40 M(-19.1%) |
Jun 2011 | - | $2.96 M(-11.9%) |
Mar 2011 | - | $3.36 M(-5.9%) |
Dec 2010 | $3.57 M | $3.57 M(+6.6%) |
Sep 2010 | - | $3.35 M(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2010 | - | $3.43 M(-37.3%) |
Mar 2010 | - | $5.47 M(+160.9%) |
Dec 2009 | $2.10 M(+19.9%) | $2.10 M(+35.9%) |
Sep 2009 | - | $1.54 M(+5.8%) |
Jun 2009 | - | $1.46 M(+42.6%) |
Mar 2009 | - | $1.02 M(-41.5%) |
Dec 2008 | $1.75 M(+17.4%) | $1.75 M(-11.0%) |
Sep 2008 | - | $1.97 M(+169.8%) |
Jun 2008 | - | $729.00 K(-66.7%) |
Mar 2008 | - | $2.19 M(+46.7%) |
Dec 2007 | $1.49 M(-2.6%) | $1.49 M(-36.8%) |
Sep 2007 | - | $2.36 M(-4.8%) |
Jun 2007 | - | $2.48 M(+40.5%) |
Mar 2007 | - | $1.76 M(+15.3%) |
Dec 2006 | $1.53 M(+7.3%) | $1.53 M(+73.1%) |
Sep 2006 | - | $884.00 K(+13.3%) |
Jun 2006 | - | $780.00 K(-3.8%) |
Mar 2006 | - | $811.00 K(-43.1%) |
Dec 2005 | $1.43 M(-56.0%) | $1.43 M(+89.4%) |
Sep 2005 | - | $753.00 K(-38.8%) |
Jun 2005 | - | $1.23 M(-19.0%) |
Mar 2005 | - | $1.52 M(-53.2%) |
Dec 2004 | $3.24 M(+38.4%) | $3.24 M(-21.2%) |
Sep 2004 | - | $4.11 M(+1.4%) |
Jun 2004 | - | $4.06 M(+71.7%) |
Mar 2004 | - | $2.36 M(+0.9%) |
Dec 2003 | $2.34 M(-7.6%) | $2.34 M(+6.4%) |
Sep 2003 | - | $2.20 M(+29.9%) |
Jun 2003 | - | $1.69 M(+5.9%) |
Mar 2003 | - | $1.60 M(-36.9%) |
Dec 2002 | $2.53 M(+79.7%) | $2.53 M(-1.9%) |
Sep 2002 | - | $2.58 M(-40.2%) |
Jun 2002 | - | $4.32 M(+136.5%) |
Mar 2002 | - | $1.83 M(+29.5%) |
Dec 2001 | $1.41 M(+0.6%) | $1.41 M(-4.9%) |
Sep 2001 | - | $1.48 M(-2.5%) |
Jun 2001 | - | $1.52 M(+45.1%) |
Mar 2001 | - | $1.05 M(-25.2%) |
Dec 2000 | $1.40 M(+180.2%) | $1.40 M(-27.2%) |
Sep 2000 | - | $1.93 M(+46.8%) |
Jun 2000 | - | $1.31 M(+113.5%) |
Mar 2000 | - | $614.00 K(+22.8%) |
Dec 1999 | $500.00 K(-37.5%) | $500.00 K(-28.6%) |
Sep 1999 | - | $700.00 K(+250.0%) |
Jun 1999 | - | $200.00 K(-75.0%) |
Mar 1999 | - | $800.00 K(0.0%) |
Dec 1998 | $800.00 K(+300.0%) | $800.00 K(+700.0%) |
Sep 1998 | - | $100.00 K(-50.0%) |
Jun 1998 | - | $200.00 K(0.0%) |
Mar 1998 | - | $200.00 K(0.0%) |
Dec 1997 | $200.00 K(-50.0%) | $200.00 K(+100.0%) |
Sep 1997 | - | $100.00 K(-66.7%) |
Jun 1997 | - | $300.00 K(0.0%) |
Mar 1997 | - | $300.00 K(-25.0%) |
Dec 1996 | $400.00 K | $400.00 K(+33.3%) |
Sep 1996 | - | $300.00 K(-25.0%) |
Jun 1996 | - | $400.00 K(0.0%) |
Mar 1996 | - | $400.00 K |
FAQ
- What is Novavax annual accounts payable?
- What is the all time high annual accounts payable for Novavax?
- What is Novavax annual accounts payable year-on-year change?
- What is Novavax quarterly accounts payable?
- What is the all time high quarterly accounts payable for Novavax?
- What is Novavax quarterly accounts payable year-on-year change?
What is Novavax annual accounts payable?
The current annual accounts payable of NVAX is $132.61 M
What is the all time high annual accounts payable for Novavax?
Novavax all-time high annual accounts payable is $216.52 M
What is Novavax annual accounts payable year-on-year change?
Over the past year, NVAX annual accounts payable has changed by -$83.91 M (-38.75%)
What is Novavax quarterly accounts payable?
The current quarterly accounts payable of NVAX is $57.52 M
What is the all time high quarterly accounts payable for Novavax?
Novavax all-time high quarterly accounts payable is $386.49 M
What is Novavax quarterly accounts payable year-on-year change?
Over the past year, NVAX quarterly accounts payable has changed by -$44.40 M (-43.56%)